These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
573 related items for PubMed ID: 15067721
21. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra. Yamamoto S, Fukae J, Mori H, Mizuno Y, Hattori N. Neurosci Lett; 2006 Apr 03; 396(3):187-91. PubMed ID: 16386370 [Abstract] [Full Text] [Related]
22. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Smits SM, Ponnio T, Conneely OM, Burbach JP, Smidt MP. Eur J Neurosci; 2003 Oct 03; 18(7):1731-8. PubMed ID: 14622207 [Abstract] [Full Text] [Related]
23. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. Anlauf M, Schäfer MK, Eiden L, Weihe E. J Comp Neurol; 2003 Apr 21; 459(1):90-111. PubMed ID: 12629668 [Abstract] [Full Text] [Related]
25. Lack of association between polymorphic microsatellites of the VMAT2 gene and Parkinson's disease in Japan. Kariya S, Hirano M, Takahashi N, Furiya Y, Ueno S. J Neurol Sci; 2005 May 15; 232(1-2):91-4. PubMed ID: 15850588 [Abstract] [Full Text] [Related]
26. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours. Jakobsen AM, Andersson P, Saglik G, Andersson E, Kölby L, Erickson JD, Forssell-Aronsson E, Wängberg B, Ahlman H, Nilsson O. J Pathol; 2001 Nov 15; 195(4):463-72. PubMed ID: 11745679 [Abstract] [Full Text] [Related]
27. Increased expression of VMAT2 in dopaminergic neurons during nicotine withdrawal. Duchemin AM, Zhang H, Neff NH, Hadjiconstantinou M. Neurosci Lett; 2009 Dec 25; 467(2):182-6. PubMed ID: 19835933 [Abstract] [Full Text] [Related]
28. Tyrosine hydroxylase and acetylcholinesterase in the domestic pig mesencephalon: an immunocytochemical and histochemical study. Ostergaard K, Holm IE, Zimmer J. J Comp Neurol; 1992 Aug 08; 322(2):149-66. PubMed ID: 1355778 [Abstract] [Full Text] [Related]
29. Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells. Chen CX, Huang SY, Zhang L, Liu YJ. Neurobiol Dis; 2005 Aug 08; 19(3):419-26. PubMed ID: 16023584 [Abstract] [Full Text] [Related]
30. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. German DC, Liang CL, Manaye KF, Lane K, Sonsalla PK. Neuroscience; 2000 Aug 08; 101(4):1063-9. PubMed ID: 11113355 [Abstract] [Full Text] [Related]
31. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL. Prog Neurobiol; 2005 Feb 08; 75(2):109-24. PubMed ID: 15784302 [Abstract] [Full Text] [Related]
32. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R. Acta Neuropathol; 2008 Jul 08; 116(1):47-55. PubMed ID: 18343932 [Abstract] [Full Text] [Related]
35. Regulation of dopamine quantal size in midbrain and hippocampal neurons. Pothos EN. Behav Brain Res; 2002 Mar 10; 130(1-2):203-7. PubMed ID: 11864736 [Abstract] [Full Text] [Related]
36. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area. Reyes S, Fu Y, Double K, Thompson L, Kirik D, Paxinos G, Halliday GM. J Comp Neurol; 2012 Aug 15; 520(12):2591-607. PubMed ID: 22252428 [Abstract] [Full Text] [Related]